Our study demonstrated a clear trend of decreasing PWV, AI and other hemodynamics variables throughout the study period (significant with baseline, Table 1 ), though the changes were not significant in comparison to placebo.
← all excerpts
Effect of rosiglitazone and ramipril on macrovasculopathy in patients with type 2 diabetes: needs longer treatment and/or higher doses?
1
—
—